Cargando…
Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapy
BACKGROUND: We recently reported a new absorbed dose conversion method, RAP (RAtio of Pharmacokinetics), for (211)At-meta-astatobenzylguanidine ((211)At-MABG) using a single biodistribution measurement, the percent injected dose/g. However, there were some mathematical ambiguities in determining the...
Autores principales: | Sakashita, Tetsuya, Matsumoto, Shojiro, Watanabe, Shigeki, Hanaoka, Hirofumi, Ohshima, Yasuhiro, Ikoma, Yoko, Ukon, Naoyuki, Sasaki, Ichiro, Higashi, Tatsuya, Higuchi, Tetsuya, Tsushima, Yoshito, Ishioka, Noriko S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665908/ https://www.ncbi.nlm.nih.gov/pubmed/34897556 http://dx.doi.org/10.1186/s40658-021-00425-z |
Ejemplares similares
-
Antitumor effects of radionuclide treatment using α-emitting meta-(211)At-astato-benzylguanidine in a PC12 pheochromocytoma model
por: Ohshima, Yasuhiro, et al.
Publicado: (2018) -
Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-(211)At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing
por: Ohshima, Yasuhiro, et al.
Publicado: (2019) -
Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer
por: Yamaguchi, Aiko, et al.
Publicado: (2019) -
Enhancing the Therapeutic Effect of 2-(211)At-astato-α-methyl-L-phenylalanine with Probenecid Loading
por: Hanaoka, Hirofumi, et al.
Publicado: (2021) -
Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication
por: Dambra, Richard, et al.
Publicado: (2022)